BNP Paribas Financial Markets’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $947K | Buy |
|
|||||
|
2025
Q2 | $22.2K | Sell |
|
|||||
|
2025
Q1 | $391K | Buy |
|
|||||
|
2024
Q4 | $337K | Buy |
|
|||||
|
2024
Q3 | $203K | Buy |
|
|||||
|
2024
Q2 | $108K | Buy |
|
|||||
|
2024
Q1 | $42.4K | Sell |
|
|||||
|
2023
Q4 | $71.3K | Sell |
|
|||||
|
2023
Q3 | $172K | Sell |
|
|||||
|
2023
Q2 | $273K | Buy |
|
|||||
|
2023
Q1 | $240K | Buy |
|
|||||
|
2022
Q4 | $432K | Buy |
|
|||||
|
2022
Q3 | $197K | Buy |
|
|||||
|
2022
Q2 | $154K | Buy |
|
|||||
|
2022
Q1 | $20.6K | Sell |
|
|||||
|
2021
Q4 | $29K | Sell |
|
|||||
|
2021
Q3 | $3.07M | Buy |
|
|||||
|
2021
Q2 | $21.6K | Sell |
|
|||||
|
2021
Q1 | $84.6K | Buy |
|
|||||
|
2020
Q4 | $76.8K | Sell |
|
|||||
|
2020
Q3 | $2.45M | Buy |
|
|||||
|
2020
Q2 | $228K | Sell |
|
|||||
|
2020
Q1 | $433K | Sell |
|
|||||
|
2019
Q4 | $4.02M | Buy |
|
|||||
|
2019
Q3 | $148K | Buy |
|
|||||
|
2019
Q2 | $133K | Sell |
|
|||||
|
2019
Q1 | $203K | Buy |
|
|||||
|
2018
Q4 | $59.8K | Sell |
|
|||||
|
2018
Q3 | $74.2K | Buy |
|
|||||
|
2018
Q2 | $62.4K | Sell |
|
|||||
|
2018
Q1 | $1.86M | Buy |
|
|||||
|
2017
Q4 | $237K | Sell |
|
|||||
|
2017
Q3 | $10.1M | Buy |
|
|||||
|
2017
Q2 | $73.4K | Buy |
|
|||||
|
2017
Q1 | $2.72K | Sell |
|
|||||
|
2016
Q4 | $3.04K | Sell |
|
|||||
|
2016
Q3 | $13.5K | Buy |
|
|||||
|
2016
Q2 | $5.58K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $84.9K | Buy |
|
|||||
|
2015
Q3 | $67.3K | Sell |
|
|||||
|
2015
Q2 | $1.79M | Buy |
|
|||||
|
2015
Q1 | $13.4K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $10.2K | Buy |
|
|||||
|
2014
Q2 | $4.32K | Buy |
|
|||||
|
2014
Q1 | $276 | Buy |
|
|||||
|
2013
Q4 | $165 | Buy |
|